Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: A pilot study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2011-05-24

AUTHORS

E. Wehr, T. R. Pieber, B. Obermayer-Pietsch

ABSTRACT

Background: Women with polycystic ovary syndrome (PCOS) frequently suffer from metabolic disturbances, in particular from insulin resistance. Accumulating evidence suggests that vitamin D deficiency may contribute to the development of insulin resistance. Hence, we aimed to examine the effect of vitamin D supplementation on metabolic and endocrine parameters in PCOS women. Methods: Fifty-seven PCOS women were included in the study. PCOS women received 20,000 IU cholecalciferol weekly for 24 weeks. Anthropometric measures, oral glucose tolerance test, and blood analyses of endocrine parameters were performed at baseline and after 12 weeks (V2) and 24 weeks (V3). Results: Forty-six PCOS women finished the study. 25-hydroxyvitamin D [25(OH)D] levels significantly increased from 28.0±11.0 ng/ml at baseline to 51.3±17.3 and 52.4±21.5 at V2 and V3, respectively (p<0.001). We observed a significant decrease of fasting and stimulated glucose (V3, p<0.05) and C-peptide levels (V2 and 3, p<0.001) after vitamin D treatment. Moreover, triglyceride and estradiol levels significantly decreased at V3 (p=0.001) and V2 (p=0.022), respectively, whereas total cholesterol (V2, p=0.008) and LDL cholesterol levels (V2, p=0.005; V3, p=0.026) significantly increased after vitamin D treatment. There were no changes in androgens. At V2, 14 out of 46 PCOS women previously affected by menstrual disturbances (30.4%) reported improvement of menstrual frequency; at V3, 23 out of 46 women (50.0%), who were oligo- or amenorrheic at baseline reported improvement. Discussion: Our results suggest that vitamin D treatment might improve glucose metabolism and menstrual frequency in PCOS women. Further randomized controlled trails are warranted to confirm our findings. More... »

PAGES

757-763

Identifiers

URI

http://scigraph.springernature.com/pub.10.3275/7748

DOI

http://dx.doi.org/10.3275/7748

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1078402354

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21613813


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "C-Peptide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholecalciferol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol, LDL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Menstruation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Menstruation Disturbances", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pilot Projects", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polycystic Ovary Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vitamin D Deficiency", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria", 
          "id": "http://www.grid.ac/institutes/grid.11598.34", 
          "name": [
            "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wehr", 
        "givenName": "E.", 
        "id": "sg:person.0754156424.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754156424.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria", 
          "id": "http://www.grid.ac/institutes/grid.11598.34", 
          "name": [
            "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pieber", 
        "givenName": "T. R.", 
        "id": "sg:person.0757263437.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757263437.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria", 
          "id": "http://www.grid.ac/institutes/grid.11598.34", 
          "name": [
            "Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Obermayer-Pietsch", 
        "givenName": "B.", 
        "id": "sg:person.01071524655.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071524655.82"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/ng0897-391", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051287855", 
          "https://doi.org/10.1038/ng0897-391"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00404-009-0958-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040584890", 
          "https://doi.org/10.1007/s00404-009-0958-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03345785", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000137059", 
          "https://doi.org/10.1007/bf03345785"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10552-009-9466-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014644603", 
          "https://doi.org/10.1007/s10552-009-9466-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00508-009-1162-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024936200", 
          "https://doi.org/10.1007/s00508-009-1162-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00394-008-0700-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010314697", 
          "https://doi.org/10.1007/s00394-008-0700-4"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-05-24", 
    "datePublishedReg": "2011-05-24", 
    "description": "Background: Women with polycystic ovary syndrome (PCOS) frequently suffer from metabolic disturbances, in particular from insulin resistance. Accumulating evidence suggests that vitamin D deficiency may contribute to the development of insulin resistance. Hence, we aimed to examine the effect of vitamin D supplementation on metabolic and endocrine parameters in PCOS women. Methods: Fifty-seven PCOS women were included in the study. PCOS women received 20,000 IU cholecalciferol weekly for 24 weeks. Anthropometric measures, oral glucose tolerance test, and blood analyses of endocrine parameters were performed at baseline and after 12 weeks (V2) and 24 weeks (V3). Results: Forty-six PCOS women finished the study. 25-hydroxyvitamin D [25(OH)D] levels significantly increased from 28.0\u00b111.0 ng/ml at baseline to 51.3\u00b117.3 and 52.4\u00b121.5 at V2 and V3, respectively (p<0.001). We observed a significant decrease of fasting and stimulated glucose (V3, p<0.05) and C-peptide levels (V2 and 3, p<0.001) after vitamin D treatment. Moreover, triglyceride and estradiol levels significantly decreased at V3 (p=0.001) and V2 (p=0.022), respectively, whereas total cholesterol (V2, p=0.008) and LDL cholesterol levels (V2, p=0.005; V3, p=0.026) significantly increased after vitamin D treatment. There were no changes in androgens. At V2, 14 out of 46 PCOS women previously affected by menstrual disturbances (30.4%) reported improvement of menstrual frequency; at V3, 23 out of 46 women (50.0%), who were oligo- or amenorrheic at baseline reported improvement. Discussion: Our results suggest that vitamin D treatment might improve glucose metabolism and menstrual frequency in PCOS women. Further randomized controlled trails are warranted to confirm our findings.", 
    "genre": "article", 
    "id": "sg:pub.10.3275/7748", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.7580457", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1088396", 
        "issn": [
          "0391-4097", 
          "1720-8386"
        ], 
        "name": "Journal of Endocrinological Investigation", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "34"
      }
    ], 
    "keywords": [
      "vitamin D treatment", 
      "PCOS women", 
      "polycystic ovary syndrome", 
      "menstrual frequency", 
      "insulin resistance", 
      "endocrine parameters", 
      "glucose metabolism", 
      "polycystic ovary syndrome women", 
      "D treatment", 
      "oral glucose tolerance test", 
      "vitamin D supplementation", 
      "vitamin D deficiency", 
      "C-peptide levels", 
      "vitamin D3 treatment", 
      "LDL cholesterol levels", 
      "glucose tolerance test", 
      "D supplementation", 
      "D deficiency", 
      "menstrual disturbances", 
      "ovary syndrome", 
      "total cholesterol", 
      "estradiol levels", 
      "tolerance test", 
      "D levels", 
      "metabolic disturbances", 
      "cholesterol levels", 
      "D3 treatment", 
      "anthropometric measures", 
      "blood analysis", 
      "pilot study", 
      "women", 
      "significant decrease", 
      "baseline", 
      "weeks", 
      "treatment", 
      "metabolism", 
      "levels", 
      "syndrome", 
      "androgens", 
      "triglycerides", 
      "IU", 
      "cholesterol", 
      "supplementation", 
      "study", 
      "V3", 
      "glucose", 
      "deficiency", 
      "V2", 
      "effect", 
      "disturbances", 
      "resistance", 
      "improvement", 
      "frequency", 
      "findings", 
      "evidence", 
      "decrease", 
      "measures", 
      "test", 
      "changes", 
      "trails", 
      "development", 
      "oligo", 
      "analysis", 
      "results", 
      "parameters"
    ], 
    "name": "Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: A pilot study", 
    "pagination": "757-763", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1078402354"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.3275/7748"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21613813"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.3275/7748", 
      "https://app.dimensions.ai/details/publication/pub.1078402354"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:29", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_537.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.3275/7748"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.3275/7748'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.3275/7748'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.3275/7748'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.3275/7748'


 

This table displays all metadata directly associated to this object as RDF triples.

229 TRIPLES      21 PREDICATES      112 URIs      98 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.3275/7748 schema:about N01940daa9dd842d5a5c53000a8432cf0
2 N0afaf2c2c2e149eb8f3d1b8ee695f4eb
3 N193eed8aa3f4431988205d0e6ca15ad7
4 N245562a60c3847e9b40945a54eb2afed
5 N3454c5d9e53447eabc64f5402af86ee2
6 N35cfcf1b7bd0427c8b17a9997a8df574
7 N5f0747abb7b74b6a8fdb802253b848a0
8 N7f364dba7f0a4d7e8fd29113b92a2aa6
9 N8bbe5b74cc8641549165b7f920034f48
10 N9624c1d9b6164be58fbcde273d432d2d
11 Na743a68bc5cb4e2e9ff17fd851e446da
12 Nc1f4b320d4d2495ba91d409c33ad66cf
13 Ne0bf4f86aad3461693e0c4d5d6246363
14 Ne1b9c0f964234e3980e45a3f9cc4a411
15 Nfd0b80c6797b4d6d968bb3c25ec493cf
16 Nff6007cc824c4b2e931264a1d5bbb184
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author Nf1401d1607ba4f1aa549644a597b9be5
20 schema:citation sg:pub.10.1007/bf03345785
21 sg:pub.10.1007/s00394-008-0700-4
22 sg:pub.10.1007/s00404-009-0958-7
23 sg:pub.10.1007/s00508-009-1162-2
24 sg:pub.10.1007/s10552-009-9466-0
25 sg:pub.10.1038/ng0897-391
26 schema:datePublished 2011-05-24
27 schema:datePublishedReg 2011-05-24
28 schema:description Background: Women with polycystic ovary syndrome (PCOS) frequently suffer from metabolic disturbances, in particular from insulin resistance. Accumulating evidence suggests that vitamin D deficiency may contribute to the development of insulin resistance. Hence, we aimed to examine the effect of vitamin D supplementation on metabolic and endocrine parameters in PCOS women. Methods: Fifty-seven PCOS women were included in the study. PCOS women received 20,000 IU cholecalciferol weekly for 24 weeks. Anthropometric measures, oral glucose tolerance test, and blood analyses of endocrine parameters were performed at baseline and after 12 weeks (V2) and 24 weeks (V3). Results: Forty-six PCOS women finished the study. 25-hydroxyvitamin D [25(OH)D] levels significantly increased from 28.0±11.0 ng/ml at baseline to 51.3±17.3 and 52.4±21.5 at V2 and V3, respectively (p<0.001). We observed a significant decrease of fasting and stimulated glucose (V3, p<0.05) and C-peptide levels (V2 and 3, p<0.001) after vitamin D treatment. Moreover, triglyceride and estradiol levels significantly decreased at V3 (p=0.001) and V2 (p=0.022), respectively, whereas total cholesterol (V2, p=0.008) and LDL cholesterol levels (V2, p=0.005; V3, p=0.026) significantly increased after vitamin D treatment. There were no changes in androgens. At V2, 14 out of 46 PCOS women previously affected by menstrual disturbances (30.4%) reported improvement of menstrual frequency; at V3, 23 out of 46 women (50.0%), who were oligo- or amenorrheic at baseline reported improvement. Discussion: Our results suggest that vitamin D treatment might improve glucose metabolism and menstrual frequency in PCOS women. Further randomized controlled trails are warranted to confirm our findings.
29 schema:genre article
30 schema:isAccessibleForFree false
31 schema:isPartOf N5bcd39ad92134e2689ae8cd4fa6d83e9
32 N7a51b93861d040a6bee012fb80d89e4f
33 sg:journal.1088396
34 schema:keywords C-peptide levels
35 D deficiency
36 D levels
37 D supplementation
38 D treatment
39 D3 treatment
40 IU
41 LDL cholesterol levels
42 PCOS women
43 V2
44 V3
45 analysis
46 androgens
47 anthropometric measures
48 baseline
49 blood analysis
50 changes
51 cholesterol
52 cholesterol levels
53 decrease
54 deficiency
55 development
56 disturbances
57 effect
58 endocrine parameters
59 estradiol levels
60 evidence
61 findings
62 frequency
63 glucose
64 glucose metabolism
65 glucose tolerance test
66 improvement
67 insulin resistance
68 levels
69 measures
70 menstrual disturbances
71 menstrual frequency
72 metabolic disturbances
73 metabolism
74 oligo
75 oral glucose tolerance test
76 ovary syndrome
77 parameters
78 pilot study
79 polycystic ovary syndrome
80 polycystic ovary syndrome women
81 resistance
82 results
83 significant decrease
84 study
85 supplementation
86 syndrome
87 test
88 tolerance test
89 total cholesterol
90 trails
91 treatment
92 triglycerides
93 vitamin D deficiency
94 vitamin D supplementation
95 vitamin D treatment
96 vitamin D3 treatment
97 weeks
98 women
99 schema:name Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: A pilot study
100 schema:pagination 757-763
101 schema:productId N2af062a5b5e545a693cf19ac40ed79e6
102 N30de1f2a684147e9a6112464ac9fc5c0
103 N790a8f7bf0d4401f9b7e67d2a103833c
104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078402354
105 https://doi.org/10.3275/7748
106 schema:sdDatePublished 2022-12-01T06:29
107 schema:sdLicense https://scigraph.springernature.com/explorer/license/
108 schema:sdPublisher N236898634fd94dd5939a0c0a7de18a6d
109 schema:url https://doi.org/10.3275/7748
110 sgo:license sg:explorer/license/
111 sgo:sdDataset articles
112 rdf:type schema:ScholarlyArticle
113 N01940daa9dd842d5a5c53000a8432cf0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Adult
115 rdf:type schema:DefinedTerm
116 N0afaf2c2c2e149eb8f3d1b8ee695f4eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Cholesterol, LDL
118 rdf:type schema:DefinedTerm
119 N193eed8aa3f4431988205d0e6ca15ad7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Humans
121 rdf:type schema:DefinedTerm
122 N236898634fd94dd5939a0c0a7de18a6d schema:name Springer Nature - SN SciGraph project
123 rdf:type schema:Organization
124 N245562a60c3847e9b40945a54eb2afed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Pilot Projects
126 rdf:type schema:DefinedTerm
127 N24b2cde45f8f4bcc9d74725abaa80e73 rdf:first sg:person.01071524655.82
128 rdf:rest rdf:nil
129 N2af062a5b5e545a693cf19ac40ed79e6 schema:name dimensions_id
130 schema:value pub.1078402354
131 rdf:type schema:PropertyValue
132 N30de1f2a684147e9a6112464ac9fc5c0 schema:name doi
133 schema:value 10.3275/7748
134 rdf:type schema:PropertyValue
135 N3454c5d9e53447eabc64f5402af86ee2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Polycystic Ovary Syndrome
137 rdf:type schema:DefinedTerm
138 N35cfcf1b7bd0427c8b17a9997a8df574 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Cholesterol
140 rdf:type schema:DefinedTerm
141 N5bcd39ad92134e2689ae8cd4fa6d83e9 schema:volumeNumber 34
142 rdf:type schema:PublicationVolume
143 N5f0747abb7b74b6a8fdb802253b848a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Adolescent
145 rdf:type schema:DefinedTerm
146 N790a8f7bf0d4401f9b7e67d2a103833c schema:name pubmed_id
147 schema:value 21613813
148 rdf:type schema:PropertyValue
149 N7a51b93861d040a6bee012fb80d89e4f schema:issueNumber 10
150 rdf:type schema:PublicationIssue
151 N7f364dba7f0a4d7e8fd29113b92a2aa6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Female
153 rdf:type schema:DefinedTerm
154 N85b222f07967483089f6b27dc18579df rdf:first sg:person.0757263437.98
155 rdf:rest N24b2cde45f8f4bcc9d74725abaa80e73
156 N8bbe5b74cc8641549165b7f920034f48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Administration, Oral
158 rdf:type schema:DefinedTerm
159 N9624c1d9b6164be58fbcde273d432d2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Menstruation Disturbances
161 rdf:type schema:DefinedTerm
162 Na743a68bc5cb4e2e9ff17fd851e446da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name C-Peptide
164 rdf:type schema:DefinedTerm
165 Nc1f4b320d4d2495ba91d409c33ad66cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Prospective Studies
167 rdf:type schema:DefinedTerm
168 Ne0bf4f86aad3461693e0c4d5d6246363 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Cholecalciferol
170 rdf:type schema:DefinedTerm
171 Ne1b9c0f964234e3980e45a3f9cc4a411 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Blood Glucose
173 rdf:type schema:DefinedTerm
174 Nf1401d1607ba4f1aa549644a597b9be5 rdf:first sg:person.0754156424.63
175 rdf:rest N85b222f07967483089f6b27dc18579df
176 Nfd0b80c6797b4d6d968bb3c25ec493cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Vitamin D Deficiency
178 rdf:type schema:DefinedTerm
179 Nff6007cc824c4b2e931264a1d5bbb184 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Menstruation
181 rdf:type schema:DefinedTerm
182 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
183 schema:name Medical and Health Sciences
184 rdf:type schema:DefinedTerm
185 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
186 schema:name Clinical Sciences
187 rdf:type schema:DefinedTerm
188 sg:grant.7580457 http://pending.schema.org/fundedItem sg:pub.10.3275/7748
189 rdf:type schema:MonetaryGrant
190 sg:journal.1088396 schema:issn 0391-4097
191 1720-8386
192 schema:name Journal of Endocrinological Investigation
193 rdf:type schema:Periodical
194 sg:person.01071524655.82 schema:affiliation grid-institutes:grid.11598.34
195 schema:familyName Obermayer-Pietsch
196 schema:givenName B.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071524655.82
198 rdf:type schema:Person
199 sg:person.0754156424.63 schema:affiliation grid-institutes:grid.11598.34
200 schema:familyName Wehr
201 schema:givenName E.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0754156424.63
203 rdf:type schema:Person
204 sg:person.0757263437.98 schema:affiliation grid-institutes:grid.11598.34
205 schema:familyName Pieber
206 schema:givenName T. R.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0757263437.98
208 rdf:type schema:Person
209 sg:pub.10.1007/bf03345785 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000137059
210 https://doi.org/10.1007/bf03345785
211 rdf:type schema:CreativeWork
212 sg:pub.10.1007/s00394-008-0700-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010314697
213 https://doi.org/10.1007/s00394-008-0700-4
214 rdf:type schema:CreativeWork
215 sg:pub.10.1007/s00404-009-0958-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040584890
216 https://doi.org/10.1007/s00404-009-0958-7
217 rdf:type schema:CreativeWork
218 sg:pub.10.1007/s00508-009-1162-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024936200
219 https://doi.org/10.1007/s00508-009-1162-2
220 rdf:type schema:CreativeWork
221 sg:pub.10.1007/s10552-009-9466-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014644603
222 https://doi.org/10.1007/s10552-009-9466-0
223 rdf:type schema:CreativeWork
224 sg:pub.10.1038/ng0897-391 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051287855
225 https://doi.org/10.1038/ng0897-391
226 rdf:type schema:CreativeWork
227 grid-institutes:grid.11598.34 schema:alternateName Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria
228 schema:name Department of Internal Medicine, Division of Endocrinology and Nuclear Medicine, Medical University of Graz, Graz, Austria
229 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...